Literature DB >> 17321990

Carcinoembryonic antigen-producing multiple myeloma detected by a transcription-reverse transcription concerted reaction system.

Ken Kaito1, Hiroko Otsubo, Shinobu Takahara, Miyuki Hyouki, Masaki Abe, Ikurou Abe, Noriko Usui.   

Abstract

Multiple myeloma is a disease involving the clonal evolution of plasma cells that produce monoclonal immunoglobulin; however, other products, such as ammonia and amylase, reportedly are secreted by neoplastic plasma cells. We describe a patient with immunoglobulin A (IgA) myeloma who showed a high serum level of carcinoembryonic antigen (CEA) that correlated well with disease status and IgA level. We detected CEA-specific messenger RNA in plasma cells by means of a recently introduced rapid and quantitative RNA-amplification system, the transcription-reverse transcription concerted reaction system. This report is the first of a patient with a diagnosis of CEA-producing multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17321990     DOI: 10.1532/IJH97.06169

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Intercalation activating fluorescence DNA probe and its application to homogeneous quantification of a target sequence by isothermal sequence amplification in a closed vessel.

Authors:  Takahiko Ishiguro; Juichi Saitoh; Ryuichi Horie; Toshinori Hayashi; Tetsuya Ishizuka; Shigeo Tsuchiya; Kiyoshi Yasukawa; Takahiro Kido; Yoshitsugu Nakaguchi; Mitsuaki Nishibuchi; Kunihiro Ueda
Journal:  Anal Biochem       Date:  2003-03-01       Impact factor: 3.365

2.  Rapid detection of Mycobacterium tuberculosis in respiratory samples by transcription-reverse transcription concerted reaction with an automated system.

Authors:  Shunji Takakura; Shigeo Tsuchiya; Yuichi Isawa; Kiyoshi Yasukawa; Toshinori Hayashi; Motohisa Tomita; Katsuhiro Suzuki; Tatsuro Hasegawa; Takanori Tagami; Atsuyuki Kurashima; Satoshi Ichiyama
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

3.  Amylase: a disease activity index in multiple myeloma?

Authors:  Massimiliano Pinelli; Massimo Bindi; Javier Rosada; Paola Scatena; Maido Castiglioni
Journal:  Leuk Lymphoma       Date:  2006-01

4.  A patient with ammonia-producing multiple myeloma showing hyperammonemic encephalopathy.

Authors:  Y Takimoto; F Imanaka; Y Hayashi; S Morioka
Journal:  Leukemia       Date:  1996-05       Impact factor: 11.528

5.  Fluorescence detection of specific sequence of nucleic acids by oxazole yellow-linked oligonucleotides. Homogeneous quantitative monitoring of in vitro transcription.

Authors:  T Ishiguro; J Saitoh; H Yawata; M Otsuka; T Inoue; Y Sugiura
Journal:  Nucleic Acids Res       Date:  1996-12-15       Impact factor: 16.971

6.  Amylase producing multiple myeloma.

Authors:  H Matsuzaki; K Takatsuki
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

Review 7.  [The carcinoembryonic antigen: apropos of an old friend].

Authors:  Félix Ignacio Téllez-Avila; Sandra Minerva García-Osogobio
Journal:  Rev Invest Clin       Date:  2005 Nov-Dec       Impact factor: 1.451

8.  Genetic analysis of amylase-producing cell lines: ectopic activation of the amylase gene by translocation.

Authors:  H Hata; H Matsuzaki; I Sanada; K Takatsuki
Journal:  Jpn J Clin Oncol       Date:  1990-09       Impact factor: 3.019

Review 9.  Amylase-producing IgD-type multiple myeloma.

Authors:  A Delannoy; J Hamels; C Mecucci; P Fally; G Wallef; C de Fooz; B Carlier
Journal:  J Intern Med       Date:  1992-11       Impact factor: 8.989

10.  In vitro excess ammonia production in human myeloma cell lines.

Authors:  T Otsuki; O Yamada; H Sakaguchi; T Ichiki; K Kouguchi; H Wada; H Hata; Y Yawata; A Ueki
Journal:  Leukemia       Date:  1998-07       Impact factor: 11.528

View more
  1 in total

1.  Multiple myeloma presenting as CEA-producing rectal cancer.

Authors:  Giampaolo Talamo; Amitkumar Barochia; Maurizio Zangari; Thomas P Loughran
Journal:  Rare Tumors       Date:  2010-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.